1887

Abstract

Antimicrobial resistance in spp. is of grave concern, more so in quinolone-resistant and extended-spectrum -lactamase (ESBL)-producing isolates that cause complicated infections. The MIC of azithromycin, ciprofloxacin, cefixime, cefepime, ceftriaxone, gatifloxacin, imipenem, levofloxacin, meropenem and ofloxacin (E-test strip) and tigecycline and faropenem (agar dilution) against 210 spp. was determined. MIC (defined as the antimicrobial concentration thatinhibited growth of 90 % of the strains) of the carbapenems (imipenem and meropenem) for Typhi and Paratyphi A was 0.064 μg ml. MIC of faropenem was 0.25 μg ml for . Typhi, . Paratyphi A and Typhimurium. The MIC of azithromycin for all spp. ranged from 8 to 16 μg ml. Tigecycline showed an MIC of 2 μg ml for . Typhi, 1 μg ml for Paratyphi A and 4 μg ml for Typhimurium. We concluded that tigecycline and the carbapenems are likely to have roles in the final stage of treatment of quinolone-resistant and ESBL-producing multidrug-resistant salmonellae.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47853-0
2009-03-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/3/337.html?itemId=/content/journal/jmm/10.1099/jmm.0.47853-0&mimeType=html&fmt=ahah

References

  1. AitMhand, R., Soukri, A., Moustaoui, N., Amarouch, H., ElMdaghri, N., Sirot, D. & Benbachir, M. ( 2002; ). Plasmid-mediated TEM-3 extended-spectrum β-lactamase production in Salmonella typhimurium in Casablanca. J Antimicrob Chemother 49, 169–172.[CrossRef]
    [Google Scholar]
  2. Brown, S. D. & Traczewski, M. M. ( 2007; ). Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. J Clin Microbiol 45, 2173–2179.[CrossRef]
    [Google Scholar]
  3. Butler, T., Sirdhar, C. B., Daga, M. K., Pathak, K., Pandit, R. B., Khakhria, R., Potkar, C. N. & Zelasky, M. T. ( 1999; ). Treatment of typhoid fever with azithromycin vs chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 44, 243–250.[CrossRef]
    [Google Scholar]
  4. Capoor, M. R., Nair, D., Hasan, A. S., Aggarwal, P. & Gupta, B. ( 2006; ). Narrowing therapeutic options in typhoid fever, India. Southeast Asian J Trop Med Public Health 37, 1170–1174.
    [Google Scholar]
  5. Capoor, M. R., Rawat, D., Nair, D., Hasan, A. S., Deb, M., Aggarwal, P. & Pillai, P. K. ( 2007; ). In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol 56, 1490–1494.[CrossRef]
    [Google Scholar]
  6. CLSI ( 2006; ). Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement. CLSI Document M100–S16, 26. Wayne, PA: CLSI.
  7. Cooke, F. J., Wain, J. & Threlfall, E. J. ( 2006; ). Fluoroquinolone resistance in Salmonella enterica serovar Typhi. BMJ 333, 353–354.
    [Google Scholar]
  8. Egorova, S., Kaftyreva, L., Grimont, P. A. D. & Weill, F. X. ( 2007; ). Prevalence and characterization of extended-spectrum cephalosporin-resistant nontyphoidal Salmonellae isolates in adults in Saint Petersburg, Russia (2002–2005). Microb Drug Resist 13, 102–107.[CrossRef]
    [Google Scholar]
  9. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee ( 2006; ). EUCAST technical note on tigecycline. Clin Microbiol Infect 12, 1147–1149.[CrossRef]
    [Google Scholar]
  10. Frenck, R. W., Jr, Mansour, A., Nakhla, I., Sultan, Y., Putnam, S., Wierzba, T., Morsy, M. & Knirsch, C. ( 2004; ). Short course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 38, 951–957.[CrossRef]
    [Google Scholar]
  11. Fritsche, T. R., Strabala, P. A., Sader, H. S., Dowzicky, M. J. & Jones, R. N. ( 2005; ). Activity of tigecycline tested against a global collection of Enterobacteriaceae including tetracycline-resistant isolates. Diagn Microbiol Infect Dis 52, 209–213.[CrossRef]
    [Google Scholar]
  12. Girgis, N. I., Butler, T., Frenck, R. W., Sultan, Y., Brown, F. M., Tribble, D., Johnson, R. B. & Khakhria, R. ( 1999; ). Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 43, 1441–1444.
    [Google Scholar]
  13. Harish, B. N., Menezes, G. A., Sarangapani, K. & Parija, S. C. ( 2006; ). Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry. Indian J Med Res 124, 585–587.
    [Google Scholar]
  14. Joshi, S. & Amarnath, S. K. ( 2007; ). Fluoroquinolone resistance in S. Typhi and S. Paratyphi A in Banglore, India. Trans R Soc Trop Med Hyg 101, 308–310.[CrossRef]
    [Google Scholar]
  15. Kownhar, H., Shankar, E. M., Rajan, R. & Rao, U. A. ( 2007; ). Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 56, 136–137.[CrossRef]
    [Google Scholar]
  16. Livermore, D. M. ( 2005; ). Tigecycline: What is it, and where should it be used? J Antimicrob Chemother 56, 611–614.[CrossRef]
    [Google Scholar]
  17. Morosini, M. I., Garcia-Castillo, M., Coque, T. M., Valverde, A., Novais, A., Loza, E., Baquero, F. & Canton, F. ( 2006; ). Antibiotic coresistance in extended spectrum-β-lactamase producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50, 2695–2699.[CrossRef]
    [Google Scholar]
  18. Old, D. C. ( 1996; ). Salmonella. In Mackie and McCartney Practical Medical Microbiology, 14th edn, pp. 385–404. Edited by J. G. Collee, A. G. Fraser, B. P. Marmion & A. Simmons. Edinburgh: Churchill Livingstone.
  19. Otkun, M., Erdem, B., Akata, F., Tatman-Otkun, M., Gerceker, D., Yagci, S. & Ozkan, E. ( 2001; ). Antibiotic resistance patterns and plasmid profiles of Salmonella typhimurium isolates in Turkey. Eur J Clin Microbiol Infect Dis 20, 206–209.[CrossRef]
    [Google Scholar]
  20. Parry, C. M., Ho, V. A., Phuong, L. T., Bay, P. V., Lanh, M. N., Tung, L. T., Tham, N. T., Wain, J. & Hien, T. T. ( 2007; ). A randomized controlled comparison of ofloxacin, azithromycin and ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 51, 819–825.[CrossRef]
    [Google Scholar]
  21. Piddock, L. J. V., Johnson, M. M. & Webber, M. A. ( 2003; ). Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. J Antimicrob Chemother 52, 500–502.[CrossRef]
    [Google Scholar]
  22. Pokharel, B. M., Koirala, J., Dahal, R. K., Mishra, S. K., Khadga, P. K. & Tuladhar, N. R. ( 2006; ). Multidrug-resistant and extended-spectrum β-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 10, 434–438.[CrossRef]
    [Google Scholar]
  23. Saha, S. K., Talukder, S. Y., Islam, M. & Saha, S. ( 1999; ). A highly ceftriaxone resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 18, 387 [CrossRef]
    [Google Scholar]
  24. Sorbera, L. A., Del Fresno, N., Castaner, R. M. & Rabasseda, X. ( 2002; ). Faropenem daloxate. Drugs Fut 27, 223 [CrossRef]
    [Google Scholar]
  25. Sun, H. Y., Tseng, S. P., Hsueh, P. R., Hung, C. C., Hsieh, S. M., Teng, L. J. & Ho, S. W. ( 2005; ). Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection. Clin Infect Dis 40, 208–209.[CrossRef]
    [Google Scholar]
  26. Weill, F. X., Guesnier, F., Guibert, V., Timinouni, M., Demartin, M., Polomack, L. & Grimont, P. A. D. ( 2006; ). Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003). J Clin Microbiol 44, 700–708.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47853-0
Loading
/content/journal/jmm/10.1099/jmm.0.47853-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error